Contra Krugman, episode 139.

Welcome to the podcast that takes apart Paul Kruikman's New York Times column.

Join us as Tom Woods and Bob Murphy teach economics by uncovering and dissecting the arrows of Krugman.

Nobel Prize winner, newspaper columnist, and Destroyer of Nations.

It's time for Contra Krukman.

Folks, if you are not on my legendary email list, you are missing out on all sorts of inner circle

goodness. Hop on that list and get a free e-book at the same time over at tom's freebooks.com.

Folks, for a while now, I've been telling you about the Lara Murphy report, a financial

publication that looks at the markets from the perspective of Austrian economics.

If you've been on the fence, well, now's your time to get off the fence because the April

2018 issue as a great one that applies Austrian business cycle theory specifically to our current situation looking at bond yields, other data.

We've also got an interview with Joe Salerno talking about the Austrian definition of the money supply and how it's relevant to today.

So I encourage you to check out the sample issues and subscribe at contra krugman.com slash lmr.

Hey, everybody, Tom and Bob here with another episode of Contra Krugman.

We got a doozy for you today.

We got Krugman talking about drug prices, and he is unconvinced that Donald Trump is going to be lowering drug prices.

So he's got a healthy

skepticism of government claims. That's a good first start. By the way, Bob and I would like to

extend a big thank you to all you good folks who tell your friends and family about Contra Krugman,

who post the episodes on social media. The show is called Contra Krugman.

There is an audience of tens of millions out there, so help us find them. And we really appreciate

those of you. I mean, there are particularly people I see in my Facebook feed who are always sharing

...